The m6A reader IGF2BP1 manipulates BUB1B expression to affect malignant behaviors, stem cell properties, and immune resistance of non-small-cell lung cancer stem cells
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The m6A reader IGF2BP1 manipulates BUB1B expression to affect malignant behaviors, stem cell properties, and immune resistance of non-small-cell lung cancer stem cells
Authors
Keywords
-
Journal
CYTOTECHNOLOGY
Volume 75, Issue 6, Pages 517-532
Publisher
Springer Science and Business Media LLC
Online
2023-09-21
DOI
10.1007/s10616-023-00594-y
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- JNK Signaling Promotes Bladder Cancer Immune Escape by Regulating METTL3-Mediated m6A Modification of PD-L1 mRNA
- (2022) Zegui Ni et al. CANCER RESEARCH
- BUBs Are New Biomarkers of Promoting Tumorigenesis and Affecting Prognosis in Breast Cancer
- (2022) Shunan Wang et al. DISEASE MARKERS
- Allosteric Regulation of IGF2BP1 as a Novel Strategy for the Activation of Tumor Immune Microenvironment
- (2022) Yang Liu et al. ACS Central Science
- IGF2BP1 Promotes Proliferation of Neuroendocrine Neoplasms by Post-Transcriptional Enhancement of EZH2
- (2022) Florian Sperling et al. Cancers
- N6-methyladenosine (m6A) reader IGF2BP1 accelerates gastric cancer aerobic glycolysis in c-Myc-dependent manner
- (2022) Fan Luo et al. EXPERIMENTAL CELL RESEARCH
- Construction and validation of prognostic prediction established on N6-methyladenosine related genes in cervical squamous cell carcinoma
- (2022) Danxia Chen et al. Translational Cancer Research
- A novel hypoxic long noncoding RNA KB-1980E6.3 maintains breast cancer stem cell stemness via interacting with IGF2BP1 to facilitate c-Myc mRNA stability
- (2021) Pengpeng Zhu et al. ONCOGENE
- BUB1B promotes extrahepatic cholangiocarcinoma progression via JNK/c-Jun pathways
- (2021) Chen Yu Jiao et al. Cell Death & Disease
- Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2021) Hyuna Sung et al. CA-A CANCER JOURNAL FOR CLINICIANS
- BUB1B Overexpression Is an Independent Prognostic Marker and Associated with CD44, p53, and PD-L1 in Renal Cell Carcinoma
- (2021) Yohei Sekino et al. ONCOLOGY
- TMB in NSCLC: A Broken Dream?
- (2021) Sara Bravaccini et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- IGF2BP1 promotes the liver cancer stem cell phenotype by regulating MGAT5 mRNA stability via m6A RNA methylation
- (2021) Yichun Yang et al. STEM CELLS AND DEVELOPMENT
- The Immune Privilege of Cancer Stem Cells: A Key to Understanding Tumor Immune Escape and Therapy Failure
- (2021) Claudia Galassi et al. Cells
- Immune evasion by cancer stem cells
- (2021) Hiroyuki Tsuchiya et al. Regenerative Therapy
- m6A regulator‐mediated RNA methylation modification patterns and immune microenvironment infiltration characterization in severe asthma
- (2021) Deyang Sun et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- TCF4 and HuR mediated-METTL14 suppresses dissemination of colorectal cancer via N6-methyladenosine-dependent silencing of ARRDC4
- (2021) Hao Wang et al. Cell Death & Disease
- Long Non-Coding RNA THOR Depletion Inhibits Human Non-Small Cell Lung Cancer Cell Growth
- (2021) Peng-Fei Jiao et al. Frontiers in Oncology
- Contributions and prognostic values of m 6 A RNA methylation regulators in non‐small‐cell lung cancer
- (2020) Yang Liu et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Chelerythrine Chloride Downregulates β-Catenin and Inhibits Stem Cell Properties of Non-Small Cell Lung Carcinoma
- (2020) Win Sen Heng et al. MOLECULES
- mRNAsi Index: Machine Learning in Mining Lung Adenocarcinoma Stem Cell Biomarkers
- (2020) Yitong Zhang et al. Genes
- The oncofetal RNA-binding protein IGF2BP1 is a druggable, post-transcriptional super-enhancer of E2F-driven gene expression in cancer
- (2020) Simon Müller et al. NUCLEIC ACIDS RESEARCH
- IGF2BP1 silencing inhibits proliferation and induces apoptosis of high glucose-induced non-small cell lung cancer cells by regulating Netrin-1
- (2020) Jiawen Zhang et al. ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
- Bioinformatic analysis revealing mitotic spindle assembly regulated NDC80 and MAD2L1 as prognostic biomarkers in non-small cell lung cancer development
- (2020) Rong Wei et al. BMC Medical Genomics
- PD-L1+ lung cancer stem cells modify the metastatic lymph-node immunomicroenvironment in nsclc patients
- (2020) A. Raniszewska et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Circular RNA circ-CPA4/ let-7 miRNA/PD-L1 axis regulates cell growth, stemness, drug resistance and immune evasion in non-small cell lung cancer (NSCLC)
- (2020) Weijun Hong et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Identification of Biomarkers for Controlling Cancer Stem Cell Characteristics in Bladder Cancer by Network Analysis of Transcriptome Data Stemness Indices
- (2019) Shen Pan et al. Frontiers in Oncology
- RNA-binding protein IGF2BP1 maintains leukemia stem cell properties by regulating HOXB4, MYB, and ALDH1A1
- (2019) Irina A. Elcheva et al. LEUKEMIA
- Dynamic transcriptomic m6A decoration: writers, erasers, readers and functions in RNA metabolism
- (2018) Ying Yang et al. CELL RESEARCH
- Recognition of RNA N6-methyladenosine by IGF2BP proteins enhances mRNA stability and translation
- (2018) Huilin Huang et al. NATURE CELL BIOLOGY
- Exosomal PD-L1 contributes to immunosuppression and is associated with anti-PD-1 response
- (2018) Gang Chen et al. NATURE
- Epigenetics in cancer stem cells
- (2017) Tan Boon Toh et al. Molecular Cancer
- Current WHO guidelines and the critical role of immunohistochemical markers in the subclassification of non-small cell lung carcinoma (NSCLC): Moving from targeted therapy to immunotherapy
- (2017) Lais Osmani et al. SEMINARS IN CANCER BIOLOGY
- Moving Immune Checkpoint Blockade in Thoracic Tumors beyond NSCLC
- (2016) Francesco Facchinetti et al. Journal of Thoracic Oncology
- Control of PD-L1 Expression by Oncogenic Activation of the AKT–mTOR Pathway in Non–Small Cell Lung Cancer
- (2015) Kristin J. Lastwika et al. CANCER RESEARCH
- Introduction to The 2015 World Health Organization Classification of Tumors of the Lung, Pleura, Thymus, and Heart
- (2015) William D. Travis et al. Journal of Thoracic Oncology
- N6-methyladenosine-dependent regulation of messenger RNA stability
- (2013) Xiao Wang et al. NATURE
- Insulin-like growth factor 2 mRNA-binding proteins (IGF2BPs): post-transcriptional drivers of cancer progression?
- (2012) Jessica L. Bell et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Safety and Activity of Anti–PD-L1 Antibody in Patients with Advanced Cancer
- (2012) Julie R. Brahmer et al. NEW ENGLAND JOURNAL OF MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started